|
Volumn 104, Issue 3, 2015, Pages 840-849
|
Future supply chains enabled by continuous processing-opportunities and challenges May 20-21, 2014 continuous manufacturing symposium
|
Author keywords
Bioavailability; Biopharmaceuticals characterization; Chemical stability; Controlled delivery; Controlled release; Polymorphism; Processing; Tableting
|
Indexed keywords
CONTINUOUS PROCESS;
COST CONTROL;
DECENTRALIZATION;
DRUG INDUSTRY;
DRUG MANUFACTURE;
INVENTORY CONTROL;
INVESTMENT;
MANAGEMENT;
PROCESS MODEL;
QUALITY CONTROL;
REVIEW;
TECHNOLOGY;
ANIMAL;
BIOAVAILABILITY;
COST BENEFIT ANALYSIS;
DELAYED RELEASE FORMULATION;
DRUG COST;
DRUG STABILITY;
ECONOMICS;
HUMAN;
PHARMACEUTICS;
PROCEDURES;
SOLUBILITY;
STANDARDS;
SUPPLY AND DISTRIBUTION;
SYNTHESIS;
TABLET;
TRENDS;
WORKFLOW;
DELAYED RELEASE FORMULATION;
DRUG;
TABLET;
ANIMALS;
BIOLOGICAL AVAILABILITY;
COST SAVINGS;
COST-BENEFIT ANALYSIS;
DELAYED-ACTION PREPARATIONS;
DRUG COSTS;
DRUG INDUSTRY;
DRUG STABILITY;
HUMANS;
PHARMACEUTICAL PREPARATIONS;
QUALITY CONTROL;
SOLUBILITY;
TABLETS;
TECHNOLOGY, PHARMACEUTICAL;
WORKFLOW;
|
EID: 84922766086
PISSN: 00223549
EISSN: 15206017
Source Type: Journal
DOI: 10.1002/jps.24343 Document Type: Article |
Times cited : (126)
|
References (7)
|